Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease
Half of the participants received a weekly injection of two milligrams of the drug exenatide, which is a GLP-1 receptor ...
Whole Foods Magazine4h
GLP-1s & The Importance of Maintaining Muscle Health
HMB is produced naturally in our bodies during the metabolism of the essential amino acid leucine. While many of HMB’s ...
Medical News Today9h
Whose cardiovascular health do SGLT2, GLP-1 diabetes drugs benefit most?
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
Medicine Buffalo19h
Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists
A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...
Healio21h
GLP-1 does not slow Parkinson’s disease progression in phase 3 study
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Becker's Hospital Review23h
GLP-1 drug fails to slow Parkinson's: Study
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...